Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Progesterone Receptor Antibodies:
anti-Mouse (Murine) Progesterone Receptor Antibodies:
anti-Rat (Rattus) Progesterone Receptor Antibodies:
Go to our pre-filtered search.
Human Monoclonal Progesterone Receptor Primary Antibody for IHC (p) - ABIN1688782
Liu, Yang, Li, Guo, Lin, Lang, Shen, Pringle, Zhang, Fu: Invasive micropapillary mucinous carcinoma of the breast is associated with poor prognosis. in Breast cancer research and treatment 2015
Show all 64 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody for IHC (p) - ABIN1688797
Phrakonkham, Brouland, Saad, Bergès, Pimpie, Pocard, Canivenc-Lavier, Perrot-Applanat: Dietary exposure in utero and during lactation to a mixture of genistein and an anti-androgen fungicide in a rat mammary carcinogenesis model. in Reproductive toxicology (Elmsford, N.Y.) 2015
Show all 50 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody for ELISA, WB - ABIN969352
Saito, Ito, Nagase, Suzuki, Akahira, Okamura, Yaegashi, Sasano: Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma. in Cancer science 2006
Show all 5 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody for ChIP, ICC - ABIN2668242
Rochette-Egly, Lutz, Pfister, Heyberger, Scheuer, Chambon, Gaub: Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. in Biochemical and biophysical research communications 1994
Show all 5 Pubmed References
Human Polyclonal Progesterone Receptor Primary Antibody for WB - ABIN1881650
Van Belle, Van Calster, Brouckaert, Vanden Bempt, Pintens, Harvey, Murray, Naume, Wiedswang, Paridaens, Moerman, Amant, Leunen, Smeets, Drijkoningen, Wildiers, Christiaens, Vergote, Van Huffel, Neven: Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010
Show all 3 Pubmed References
Human Polyclonal Progesterone Receptor Primary Antibody for WB - ABIN1881649
Geradts, Bean, Bentley, Barry: The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features. in Cancer investigation 2010
Show all 3 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody for IF, IHC (p) - ABIN562204
Liu, Chang, Kuo, Hwa, Lin, Huang, Chen, Chang, Hsieh: Major Functional Transcriptome of an Inferred Center Regulator of an ER(-) Breast Cancer Model System. in Cancer informatics 2012
Show all 2 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody for ELISA, WB - ABIN966829
Polo, José Galindo, Martínez, Alvarez, Arévalo, Asensi, Cánoves, Cáncer, Collazos, Estrada, Gómez-Candela, Johnston, Locutura, López-Aldeguer, Lozano, Miralles, Muñoz-Sanz, Ortega, Pascua, Pedrol, Pulido, San Martín, Sanz, Viciana, Chamorro,: [Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection]. in Enfermedades infecciosas y microbiología clínica 2006
Show all 4 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody for IHC (fro), IHC - ABIN152361
Pérez, Cuadros, Benítez, Jiménez: Interaction of Alzheimer's disease amyloid beta peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain. in Journal of Alzheimer's disease : JAD 2004
Show all 2 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody for ELISA - ABIN1724699
Tung, Abdel-Hafiz, Shen, Harvell, Nitao, Richer, Sartorius, Takimoto, Horwitz: Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B. in Molecular endocrinology (Baltimore, Md.) 2006
Show all 2 Pubmed References
We investigate the impact of central histology (n = 772), immunohistochemistry for intrinsic subtyping and IHC4, and dichotomous (GG) or continuous (GGI) genomic grade (n = 472) on patient outcome and benefit from taxane chemotherapy, focusing on HR+/HER2 (show ERBB2 Antibodies)(HR: ER and/or PR)- patients (n = 459)
progesterone receptor expression status correlates with final pregnancy outcome
RA induced loss of PR binding only at the proximal site. Interestingly, RARalpha (show RARA Antibodies) was recruited to the -1.1 kb PRE and the -130 bp PRE/RARE regions with P4, but not RA alone or RA plus P4
C/EBPbeta (show CEBPB Antibodies) negatively regulates PR-B expression in glioblastoma cells.
Evaluation of progesterone expression in axillary lymph node metastasis of ER-positive, HER2 (show ERBB2 Antibodies)-negative breast cancer may enable prediction of patients who are less likely to benefit from adjuvant tamoxifen.
findings suggest that GATAD2B (show GATAD2B Antibodies) serves as an important mediator of progesterone-progesterone receptor suppression of proinflammatory and contractile genes during pregnancy; decreased GATAD2B (show GATAD2B Antibodies) expression near term may contribute to the decline in progesterone receptor function, leading to labor
We sought to determine the relation between 17-alpha hydroxyprogesterone caproate plasma concentrations, progesterone receptor single nucleotide polymorphisms and single nucleotide polymorphisms in CYP3A4 (show CYP3A4 Antibodies) and CYP3A5 (show CYP3A5 Antibodies) and spontaneous preterm birth.
the estrogen- (ER), progesterone- (PgR) and HER2/neu (show ERBB2 Antibodies) receptor status of the primary tumor with brain metastases in a series of 24 consecutive breast cancer patients, is reported.
we found that combinatorial MK-2206+progesterone treatments decreased angiogenesis and proliferation in the Pten (show PTEN Antibodies)(d/d) conditional mouse model of endometrial cancer. Taken together, these findings suggest that a combinatorial therapeutic approach utilizing Akt (show AKT1 Antibodies) inhibitors with progestins may improve the efficacy of progestin therapy for the treatment of endometrial cancer.
The interplay between intracellular progesterone receptor and PRKCA (show PKCa Antibodies)-PRKCD (show PKCd Antibodies) plays a key role in migration and invasion of human glioblastoma cells.
Glandular epithelial androgen receptor (AR (show AR Antibodies)) inactivation (with persistent stromal AR action) enhanced PTEN (show PTEN Antibodies) deletion-induced uterine pathology possibly by downregulating progesterone receptor expression in the uterus.
Studies indicate that progesterone receptor transgenic (Pgrcre/+) mitogen inducible gene 6 (Mig (show CXCL9 Antibodies)-6over) phosphatase and tensin homolog (show PTEN Antibodies) protein (Ptenf/f) knockout mice exhibited an increase of phospho-ERK1/2 (show MAPK1/3 Antibodies) and its target genes.
loss of PGR impairs kisspeptin secretory machinery and therefore that PGR plays a critical role in regulating kisspeptin secretion.
PR isoforms are differentially regulated by estradiol and that the induction of PR-B expression is associated to specific transcription factors interactions and epigenetic changes in its promoter in embryonic hypothalamic cells.
The results show that mPges-1 (show PTGES Antibodies) may be a direct downstream target gene of the progesterone receptor.
Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
generated a model to study the consequence of increased Notch (show NOTCH1 Antibodies) signaling in female reproduction and provide the first evidence, to our knowledge, that Notch (show NOTCH1 Antibodies) signaling can regulate epigenetic modification of the progesterone receptor
Calvarial cells had more potential to differentiate into osteoblasts and displayed more osteogeic markers after the PR expression was ablated from the Mx1+ cells. This indicates that PRs may play a role in the later stages of osteoblast differentiation.
progesterone receptor is a key contributor to the hypoxic ventilatory response in newborn mice
Progesterone receptor rapid and nonclassical transcriptional effects govern breast cancer growth.
Data suggest that the classical xPR-1, located at the plasma membrane, mediates reinitiation of the meiotic cell cycle in the X. laevis oocyte through a non-genomic mechanism.
Xenopus laevis progesterone receptor is capable of associating with the plasma membrane and this association is through its ligang-binding domain.
The expression of progesterone receptor in the uterotubular junction after deep intrauterine insemination with a reduced number of sperm was lower than after conventional artificial insemination and might influence sperm transportation and fertilization.
the digitonin-soluble progesterone binding protein (show PGRMC1 Antibodies) has a binding site that differs from that of membrane PR; it is concluded that more than one progesterone receptor is present in porcine spermatozoa.
The expression of mRNAs for ERalpha (show ESR1 Antibodies), ERbeta (show ESR2 Antibodies) and PR in the sow uterus differed between endometrium and myometrium as well as with stages of the estrous cycle and early pregnancy.
Pgr is widely distributed in all regions of the zebrafish brain.
The localization of Pgr suggests that it mediates progestin regulation of reproductive signaling in the brain, early germ cell proliferation in testis, and ovarian follicular functions, but not final oocyte or sperm maturation.
11 beta-hydroxysteroid dehydrogenase activity stimulated by DHP (show DPYS Antibodies) via Pgr
In vitro and in vivo effects of PGR knockdown in Luteinized granulosa cells also support the hypothesis that Progesterone enhances its own synthesis in the primate corpus luteum by promoting luteinization.
Data suggest that there are no changes in expression or localization patterns for PGR and PGRMC1 (show PGRMC1 Antibodies) (progesterone receptor membrane component 2 (show PGRMC2 Antibodies)) in endometrium in artificially cycled disease-free animals compared with an endometriosis model.
expression differences among PGR genotypes in oviduct and uterus and when differences appear during gestation
During early pregnancy mares had the same pattern of progesterone receptor in the endometrium as that reported for other mammals; namely, a loss of progesterone receptor from the endometrial epithelia but continued localization in stromal cells.
These results indicate that ptger4b expression is regulated by a genomic mechanism involving Pgr.
Progesterone upregulation of Gs proteins increases VIP (show Vip Antibodies)-induced inhibition of intestinal smooth muscle cell contraction mediated by progesterone receptor A.(progesterone receptor A)
This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap.
nuclear receptor subfamily 3 group C member 3
, p4 receptor
, Nuclear receptor subfamily 3 group C member 3
, progesterone receptor
, nuclear progesterone receptor Pgr